Showing results (871-880 of 1,355) with videos related to
Sort By:
Pageof 136
Journal of the American College of Cardiology|June 6, 2009
Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trialAlexander E Fraley, Gregory G Schwartz, Anders G Olsson, et al.Journal of the American College of Cardiology|August 23, 2003
Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trialRonald G Schwartz, Thomas A Pearson, Vijay G Kalaria, et al.JAMA Cardiology|March 7, 2019
Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 TrialPreethi Mani, Rishi Puri, Gregory G Schwartz, et al.The Laryngoscope|July 17, 1998
Surgery versus radiation therapy as single-modality treatment of tonsillar fossa carcinoma: the Roswell Park Cancer Institute experience (1971-1991)W L Hicks, M A Kuriakose, T R Loree, et al.Oncology|November 13, 2004
A phase I and pharmacokinetic study of BAY59: a novel taxaneN Ramnath, J Hamm, G Schwartz, et al.The Journal of Maternal-Fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians|March 14, 2013
Soluble TRAIL in normal pregnancy and acute pyelonephritis: a potential explanation for the susceptibility of pregnant women to microbial products and infectionPiya Chaemsaithong, Roberto Romero, Steven J Korzeniewski, et al.Carcinogenesis|January 1, 2016
Whole-exome sequencing reveals genetic variability among lung cancer cases subphenotyped for emphysemaChristine M Lusk, Angela S Wenzlaff, Greg Dyson, et al.American Heart Journal|June 22, 2015
Effects of the dual peroxisome proliferator-activated receptor activator aleglitazar in patients with Type 2 Diabetes mellitus or prediabetesErland Erdmann, Robert Califf, Hertzel C Gerstein, et al.European Journal of Preventive Cardiology|April 17, 2025
Efficacy and safety of inclisiran based on background lipid-lowering treatmentUlf Landmesser, Wolfgang Koenig, Lawrence A Leiter, et al.Ophthalmic Surgery, Lasers & Imaging Retina|July 26, 2013
Initial outcomes following intravitreal ocriplasmin for treatment of symptomatic vitreomacular adhesionBrian T Kim, Stephen G Schwartz, William E Smiddy, et al.Pageof 136